Prudential Financial’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Sell |
158,359
-45,883
| -22% | -$1.53M | 0.01% | 881 |
|
|
2025
Q1 | $5.98M | Buy |
204,242
+99,320
| +95% | +$2.91M | 0.01% | 767 |
|
|
2024
Q4 | $3.45M | Buy |
104,922
+55,400
| +112% | +$1.82M | ﹤0.01% | 1022 |
|
|
2024
Q3 | $2.2M | Sell |
49,522
-58,330
| -54% | -$2.59M | ﹤0.01% | 1444 |
|
|
2024
Q2 | $4.65M | Sell |
107,852
-86,280
| -44% | -$3.72M | 0.01% | 956 |
|
|
2024
Q1 | $5.68M | Buy |
194,132
+124,600
| +179% | +$3.64M | 0.01% | 871 |
|
|
2023
Q4 | $1.55M | Sell |
69,532
-120
| -0.2% | -$2.67K | ﹤0.01% | 1596 |
|
|
2023
Q3 | $1.72M | Sell |
69,652
-43,200
| -38% | -$1.07M | ﹤0.01% | 1460 |
|
|
2023
Q2 | $3.2M | Buy |
+112,852
| New | +$3.2M | ﹤0.01% | 1144 |
|
|
2022
Q3 | – | Sell |
-55,858
| Closed | -$1.24M | – | 2647 |
|
|
2022
Q2 | $1.24M | Buy |
55,858
+42,200
| +309% | +$935K | ﹤0.01% | 1675 |
|
|
2022
Q1 | $397K | Buy |
13,658
+2,443
| +22% | +$71K | ﹤0.01% | 2300 |
|
|
2021
Q4 | $369K | Sell |
11,215
-8,882
| -44% | -$292K | ﹤0.01% | 2323 |
|
|
2021
Q3 | $927K | Sell |
20,097
-67,353
| -77% | -$3.11M | ﹤0.01% | 1842 |
|
|
2021
Q2 | $4.82M | Buy |
+87,450
| New | +$4.82M | 0.01% | 1039 |
|
|
2020
Q2 | – | Sell |
-30,108
| Closed | -$1.07M | – | 2393 |
|
|
2020
Q1 | $1.07M | Sell |
30,108
-600
| -2% | -$21.3K | ﹤0.01% | 1661 |
|
|
2019
Q4 | $1.47M | Buy |
+30,708
| New | +$1.47M | ﹤0.01% | 1729 |
|
|
2018
Q4 | – | Sell |
-2,610
| Closed | -$201K | – | 2376 |
|
|
2018
Q3 | $201K | Buy |
2,610
+100
| +4% | +$7.7K | ﹤0.01% | 2329 |
|
|
2018
Q2 | $211K | Buy |
+2,510
| New | +$211K | ﹤0.01% | 2331 |
|